Identification |
Name: | Benzamide,N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-4-(1-piperazinylmethyl)- |
Synonyms: | N-[4-Methyl-3-[4-(pyridin-3-yl)pyrimidin-2-ylamino]phenyl]-4-[(piperazin-1-yl)methyl]benzamide;Norimatinib; STI 509-00 |
CAS: | 404844-02-6 |
Molecular Formula: | C28H29 N7 O |
Molecular Weight: | 0 |
InChI: | InChI=1/C28H29N7O/c1-20-4-9-24(17-26(20)34-28-31-12-10-25(33-28)23-3-2-11-30-18-23)32-27(36)22-7-5-21(6-8-22)19-35-15-13-29-14-16-35/h2-12,17-18,29H,13-16,19H2,1H3,(H,32,36)(H,31,33,34) |
Molecular Structure: |
|
Properties |
Density: | 1.269g/cm3 |
Refractive index: | 1.676 |
Appearance: | Off-white to pale-yellow solid |
Usage: | A metabolite of Gleevec, a tyrosine kinase inhibitor which is highly specific for BCR-ABL, the enzyme associated with chronic myelogenous leukemia (CML) and certain forms of acute lymphoblastic leukemia (ALL) |
Safety Data |
|
|